BioPharma Dive1 min read
saveThis week in charts: Biotech investors’ China bets are already paying off
This year, companies built around medicines from China have sped toward acquisitions or IPOs. Meanwhile, Summit is no longer the Wall Street darling it was in 2024.
comments(0)
5-min edit window · permanent after that